Cargando…

Prescriber Compliance With Liver Monitoring Guidelines for Pazopanib in the Postapproval Setting: Results From a Distributed Research Network

OBJECTIVES: Pazopanib received US Food and Drug Administration approval in 2009 for advanced renal cell carcinoma. During clinical development, liver chemistry abnormalities and adverse hepatic events were observed, leading to a boxed warning for hepatotoxicity and detailed label prescriber guidelin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shantakumar, Sumitra, Nordstrom, Beth L., Hall, Susan A., Djousse, Luc, van Herk-Sukel, Myrthe P.P., Fraeman, Kathy H., Gagnon, David R., Chagin, Karen, Nelson, Jeanenne J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407814/ https://www.ncbi.nlm.nih.gov/pubmed/28430700 http://dx.doi.org/10.1097/PTS.0000000000000332

Ejemplares similares

Occurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network
por: Shantakumar, Sumitra, et al.
Publicado: (2016)

Disruptions in Liver Function among Cancer Patients and Patients Treated with Tyrosine Kinase Inhibiting Drugs: Comparisons of Two Population-Based Databases
por: Landis, Sarah H., et al.
Publicado: (2013)

Incidence of New-Onset Hypertension in Cancer Patients: A Retrospective Cohort Study
por: Fraeman, Kathy H., et al.
Publicado: (2013)

Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis
por: van Herk-Sukel, Myrthe P. P., et al.
Publicado: (2012)

The progress of postapproval clinical studies on Sabin IPV
por: Shi, Li, et al.
Publicado: (2021)

Risk of heart failure among colon and rectal cancer survivors: a population‐based case–control study
por: Kuiper, Josephina G., et al.
Publicado: (2022)

Strengthening postapproval oversight in research ethics committees: Challenges and solutions
por: Shetty, Yashashri Chandrakant, et al.
Publicado: (2023)

Leadless pacemaker implant in patients with pre‐existing infections: Results from the Micra postapproval registry
por: El‐Chami, Mikhael F., et al.
Publicado: (2019)

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases
por: Ismail, Rawa K., et al.
Publicado: (2020)

Use of Erythropoiesis-Stimulating Agents Among Chemotherapy Patients With Hemoglobin Exceeding 12 Grams Per Deciliter
por: Nordstrom, Beth L., et al.
Publicado: (2008)

A steep increase in healthcare seeking behaviour in the last months before colorectal cancer diagnosis
por: Kuiper, Josephina G., et al.
Publicado: (2021)

A population‐based linked cohort of cancer and primary care data: A new source to study the management of cancer in primary care
por: Kuiper, Josephina G., et al.
Publicado: (2021)

Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review
por: Pease, Alison M, et al.
Publicado: (2017)

DuraSeal Exact Is a Safe Adjunctive Treatment for Durotomy in Spine: Postapproval Study
por: Kim, Kee D., et al.
Publicado: (2018)

Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction
por: Kruik‐Kollöffel, Willemien J., et al.
Publicado: (2016)

Postapproval clinical experience in the treatment of Dupuytren’s contracture with collagenase clostridium histolyticum (CCH): the first 1,000 days
por: Schulze, Scott M., et al.
Publicado: (2014)

Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration
por: Egilman, Alexander, et al.
Publicado: (2021)

Persistence and Compliance with Pazopanib in Patients with Advanced Renal Cell Carcinoma Within a U.S. Administrative Claims Database
por: Hackshaw, Michelle D., et al.
Publicado: (2014)

Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study
por: Weberpals, Janick, et al.
Publicado: (2017)

Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study
por: Nordstrom, Beth L., et al.
Publicado: (2022)

Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study
por: Ruiter, Rikje, et al.
Publicado: (2012)

Six‐month outcomes in postapproval HeartMate3 patients: A single‐center US experience
por: Bansal, Aditya, et al.
Publicado: (2022)

Pharmaceutically treated anxiety but not depression prior to cancer diagnosis predicts the onset of cardiovascular disease among breast cancer survivors
por: Schoormans, Dounya, et al.
Publicado: (2017)

Results of the combined U.S. multicenter postapproval study of the Nit‐Occlud PDA device for percutaneous closure of patent ductus arteriosus
por: Kobayashi, Daisuke, et al.
Publicado: (2018)

Patient burden and clinical advances associated with postapproval monotherapy cancer drug trials: a retrospective cohort study
por: Carlisle, Benjamin Gregory, et al.
Publicado: (2020)

Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivors
por: Schoormans, Dounya, et al.
Publicado: (2018)

Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study
por: Livingstone, Elisabeth, et al.
Publicado: (2014)

No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study
por: Frouws, Martine A., et al.
Publicado: (2017)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
por: Skydel, Joshua J., et al.
Publicado: (2019)

Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA
por: Hiayev, Stephany, et al.
Publicado: (2023)

Asia-Pacific Survey of Physicians on Asthma and Allergic Rhinitis (ASPAIR): physician beliefs and practices about diagnosis, assessment, and treatment of coexistent disease
por: Aggarwal, Bhumika, et al.
Publicado: (2018)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
por: Di Desidero, Teresa, et al.
Publicado: (2019)

Validation of Claims Algorithms for Progression to Metastatic Cancer in Patients with Breast, Non-small Cell Lung, and Colorectal Cancer
por: Nordstrom, Beth L., et al.
Publicado: (2016)

Pazopanib and anti-VEGF therapy
por: Drabkin, Harry A
Publicado: (2010)

Pazopanib and Statin-Induced Rhabdomyolysis
por: Logue, Jennifer M., et al.
Publicado: (2017)

Phototoxic Reaction Induced by Pazopanib
por: Udompanich, Siriorn, et al.
Publicado: (2018)

Tension Pneumothorax: Is it Sarcoma or Pazopanib?
por: Sebanayagam, Vinoja, et al.
Publicado: (2020)

A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory Decisions
por: Gatto, Nicolle M., et al.
Publicado: (2019)

Characterization and burden of severe eosinophilic asthma in New Zealand: Results from the HealthStat Database
por: Shantakumar, Sumitra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pf8ek14drc46uefs9qjm687foo